APP and Alzheimer disease: In this study, we demonstrate that deletion of murine APP exacerbates muscle weakness, motor deficits, AD lesions, and gliosis in the novel transgenic mouse line 5xFADXTg30XAPP-/- compared to 5xFADXTg30 mice.